Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
34
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Anavex Life Sciences Corporation market cap is $86.53M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Anavex Life Sciences Corporation 52 week high is $5.36 as of November 17, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Anavex Life Sciences Corporation 52 week low is $0.8003 as of November 17, 2026.
Anavex Life Sciences Corporation stock price today is $0.8176.
Anavex Life Sciences Corporation stock price yesterday was $0.9335.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Anavex Life Sciences Corporation's P/E ratio is -5.39.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Anavex Life Sciences Corporation P/B ratio is 0.674.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Anavex Life Sciences Corporation 50-day moving average is $1.71.
Anavex Life Sciences Corporation has 34 employees.